JP2619841B2 - Oral composition - Google Patents
Oral compositionInfo
- Publication number
- JP2619841B2 JP2619841B2 JP3059754A JP5975491A JP2619841B2 JP 2619841 B2 JP2619841 B2 JP 2619841B2 JP 3059754 A JP3059754 A JP 3059754A JP 5975491 A JP5975491 A JP 5975491A JP 2619841 B2 JP2619841 B2 JP 2619841B2
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- tea
- present
- oral composition
- leaf extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims description 21
- 229940092665 tea leaf extract Drugs 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 241001122767 Theaceae Species 0.000 claims 1
- 235000013616 tea Nutrition 0.000 description 20
- 244000269722 Thea sinensis Species 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 210000000214 mouth Anatomy 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000003110 anti-inflammatory effect Effects 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000606 toothpaste Substances 0.000 description 7
- 229940034610 toothpaste Drugs 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 208000028169 periodontal disease Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- -1 sucrose fatty acid ester Chemical class 0.000 description 5
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 3
- 239000001569 carbon dioxide Chemical group 0.000 description 3
- 229910002092 carbon dioxide Chemical group 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 239000000551 dentifrice Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 206010018276 Gingival bleeding Diseases 0.000 description 2
- 206010018291 Gingival swelling Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940085605 saccharin sodium Drugs 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HMGXNPBLFPRFIZ-UHFFFAOYSA-N 2-dodecanoyloxy-2-oxoethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)OC(=O)CS(O)(=O)=O HMGXNPBLFPRFIZ-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000034619 Gingival inflammation Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 229940048820 edetates Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229960001708 magnesium carbonate Drugs 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- CKVCFYYFFUHCDP-UHFFFAOYSA-M sodium;phosphoric acid;fluoride Chemical compound [F-].[Na+].OP(O)(O)=O CKVCFYYFFUHCDP-UHFFFAOYSA-M 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、口腔用組成物に関し、
詳しくは、嫌気的条件下で保存処理した茶葉抽出物を配
合してなる歯肉の抗炎症改善効果等に優れた口腔用組成
物に関するものである。The present invention relates to an oral composition,
More specifically, the present invention relates to a composition for oral cavity which is excellent in anti-inflammatory effect on gingiva and comprises a tea leaf extract preserved under anaerobic conditions.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】従来よ
り、う蝕すなわち虫歯の原因については、一般に口内に
存在するショ糖、口腔内細菌、歯の質の3つの条件が重
なることにより発生すると言われており、そのメカニズ
ムは次の様に考えられている。2. Description of the Related Art Conventionally, the cause of dental caries, that is, tooth decay, is generally caused by the overlapping of three conditions of sucrose, oral bacteria, and tooth quality existing in the mouth. It is said that the mechanism is considered as follows.
【0003】すなわち、飲食物中に含まれているショ糖
が歯面に付着した或種の口腔内細菌の分泌する酵素であ
るグルコシルトランスフェラーゼの作用を受けて粘着性
・不溶性の多糖類であるグルカンを生じ、細菌の巣たる
歯垢を形成すると共に、歯垢中で細菌は糖類を分解して
酸を生成し、この酸が歯のエナメル表面を脱灰させてう
蝕を進行させるのである。また、近年の高齢化社会への
急速な進化によりいわゆる歯周病の疾患率も増大し、そ
の予防は急務であるのも現状である。[0003] That is, sucrose contained in food and drink is subjected to the action of glucosyltransferase, an enzyme secreted by certain kinds of oral bacteria adhered to the tooth surface, and is a glucan which is a sticky and insoluble polysaccharide. In addition to the formation of plaque, which is a nest of bacteria, bacteria break down sugars in plaque to produce an acid, which demineralizes the enamel surface of the tooth and promotes caries. In addition, the disease rate of so-called periodontal disease has increased due to the rapid evolution toward an aging society in recent years, and prevention of such diseases is an urgent need at present.
【0004】歯周病は、歯の周りの組織に起こる病気の
すべてをいい、歯磨等の手入れをしっかりと行わないと
炎症が慢性的になり、歯を支持する組織が崩され、最終
的には歯を失うことになる。この病状の進行度や患者の
年齢に応じて現れるさまざまな病型を生じる。すなわ
ち、歯周病のまず最初は、歯の生え際の表面に歯垢や歯
石が付着し、歯を取り巻く歯茎が腫れて赤くなる炎症を
起こす。この炎症が長く続くと歯と歯茎の間にすきまが
でき、いわゆる歯周ポケットができる。そして、それが
更に進むとその底にある歯槽骨がしだいに消失してしま
う。歯周病は、痛みがともなわず自覚症状がないままに
病状が進んでいく慢性の炎症であるが、歯茎からの出
血、歯茎の腫れ、口臭などを伴うことが多い。[0004] Periodontal disease refers to all diseases that occur in tissues around teeth. If care is not properly made such as by brushing teeth, inflammation becomes chronic, tissue supporting teeth is destroyed, and finally, Will lose teeth. There are various types of disease that appear depending on the stage of the condition and the age of the patient. That is, at the very beginning of periodontal disease, plaque and tartar adhere to the surface of the tooth hairline, and the gums surrounding the teeth are swollen and inflamed. If this inflammation lasts for a long time, there is a gap between the teeth and the gums, so-called periodontal pockets. And as it goes further, the alveolar bone at the bottom will gradually disappear. Periodontal disease is chronic inflammation that progresses without subjective symptoms without pain, but often involves bleeding from the gums, swelling of the gums, bad breath and the like.
【0005】従来は、このような抗炎症等に効果的なも
のとして、グリチルリチン、ε−アミノカプロン酸、ビ
タミンE類、アラントイン、ヒノキチオール等の抗炎症
剤を口腔用組成物として歯磨等に配合しているが、抗炎
症作用は不十分なものであり、上記問題を解決するには
至っていない。Heretofore, as an effective anti-inflammatory agent, anti-inflammatory agents such as glycyrrhizin, ε-aminocaproic acid, vitamin Es, allantoin, hinokitiol, etc. have been blended into dentifrices as oral compositions. However, the anti-inflammatory effect is insufficient, and the above problem has not been solved.
【0006】このような状況に鑑み、本発明者らは歯周
病等の歯茎の炎症を抑える抗炎症作用の優れた口腔用組
成物に対し、鋭意研究を重ねた結果、嫌気的条件下で保
存した後、蒸気加熱処理及び/又は乾燥処理し、これを
抽出して得られた茶葉抽出物を配合することによって抗
炎症作用に効果的であることを見いだし、本発明を完成
するに至った。In view of such circumstances, the present inventors have conducted intensive studies on an oral composition having an excellent anti-inflammatory effect for suppressing gum inflammation such as periodontal disease. after saving, and steam heating treatment and / or drying process, it
It has been found that the addition of a tea leaf extract obtained by extraction is effective for anti-inflammatory action, and the present invention has been completed.
【0007】すなわち、本発明の目的は、歯肉の炎症を
抑え、改善し、歯槽膿漏、歯肉炎の予防効果に優れた口
腔用組成物を提供することにある。[0007] That is, an object of the present invention is to provide an oral composition which suppresses and improves gingival inflammation and has an excellent effect of preventing alveolar pyorrhea and gingivitis.
【0008】[0008]
【課題を解決するための手段】本発明は、茶の生葉を嫌
気的条件下で保存した後、蒸気加熱処理及び/又は乾燥
処理し、これを抽出して得られた茶葉抽出物を、その固
形分として0.01重量%以上配合したことを特徴とす
る口腔用組成物である。SUMMARY OF THE INVENTION The present invention provides a tea leaf extract obtained by storing fresh tea leaves under anaerobic conditions, subjecting them to steam heating treatment and / or drying treatment , and extracting them. An oral composition characterized by being incorporated in an amount of 0.01% by weight or more as a solid content.
【0009】以下、本発明の構成に関し、説明する。茶
は、嗜好飲料であるばかりでなく、茶に含まれているビ
タミンC、カフェイン、アミノ酸類等の生理的作用によ
り保健飲料として広く愛飲されている。茶葉の製法は、
古来種々な国々によって様々な方法がとられてきたが、
一般的には玉露、抹茶、煎茶、番茶等の不発酵法、ウー
ロン茶等の半発酵法、紅茶等の発酵法に分類することが
できる。そして、これらいずれの茶もその製造工程中の
作業は全て酸素の存在下で行なわれている。Hereinafter, the configuration of the present invention will be described. Tea is not only a favorite beverage, but is also widely consumed as a health drink due to the physiological effects of vitamin C, caffeine, amino acids and the like contained in the tea. The method of making tea leaves is
Various methods have been adopted by various countries since ancient times,
Generally, it can be classified into non-fermentation methods such as gyokuro, matcha, sencha and bancha, semi-fermentation methods such as oolong tea, and fermentation methods such as black tea. All the operations during the manufacturing process of any of these teas are performed in the presence of oxygen.
【0010】しかしながら、最近血圧降下作用を強化し
た茶の製造法が注目されている。この方法は一般に緑
茶、抹茶等の不発酵法では、茶葉を製造する工程中で、
茶葉を蒸熱する前処理として空気を完全に窒素或いは二
酸化炭素で置換した密閉容器中で5〜30時間封印保存
し、又、紅茶等の発酵法では、茶葉を萎周し揉捻する前
工程として、同じく窒素或いは二酸化炭素で置換した密
閉容器中に封印保存する方法である。この処理を施した
茶葉抽出物中のγ−アミノ酪酸の含有量は最大300m
g/100gであるのに対して、このような処理をしな
い茶葉抽出物では30mg/100gと、約10分の1
しか含まれていない。従って、従来の製法で処理した茶
葉抽出物では血圧降下作用が殆ど発現しないが、嫌気的
条件下で保存処理した前記の茶葉抽出物は優れた血圧降
下作用を示すという利点を有している。[0010] However, recently, a method for producing tea with enhanced blood pressure lowering action has attracted attention. This method is generally used in non-fermentation methods such as green tea and matcha in the process of producing tea leaves.
As a pretreatment for steaming tea leaves, sealed and stored for 5 to 30 hours in a closed container in which air has been completely replaced with nitrogen or carbon dioxide. Similarly, it is a method of sealing and storing in a sealed container replaced with nitrogen or carbon dioxide. The content of γ-aminobutyric acid in the tea leaf extract subjected to this treatment is up to 300 m.
g / 100 g, whereas 30 mg / 100 g for a tea leaf extract not subjected to such treatment is about 1/10.
Only included. Therefore, the tea leaf extract treated by the conventional production method hardly exhibits a blood pressure lowering effect, but the tea leaf extract preserved under anaerobic conditions has an advantage of exhibiting an excellent blood pressure lowering effect.
【0011】本発明者等は、摘採した茶の生葉を収容し
た容器中の空気を二酸化炭素ガス、窒素ガス等の不活性
ガスと充分に置換せしめた後、容器を密閉して、例えば
室温では3時間以上放置する(茶葉を嫌気的条件で保存
処理する)ことによって、γ−アミノ酪酸の含有量が著
しく増加する現象に着目して鋭意研究した結果、嫌気的
条件下で保存処理した茶葉を、例えば10〜30分間蒸
気加熱した後、自然乾燥するか、或いは80℃以上乾燥
器内に5時間以上入れて乾燥した茶葉を、水、水混和性
有機液体、水と水混和性有機液体との混和物等の溶媒の
沸点下で30〜60分間抽出を行なうとよいことを見出
した。この抽出物は、通常の方法で濃縮処理するか、又
は必要に応じて、活性白土、クロマトグラフィー等で精
製処理した後、減圧下で濃縮処理することにより、固形
物(有効成分)が得られるものである。The present inventors have sufficiently replaced the air in a container containing freshly picked tea leaves with an inert gas such as carbon dioxide gas or nitrogen gas, and then sealed the container. As a result of intensive research focusing on the phenomenon that the content of γ-aminobutyric acid is significantly increased by leaving the tea leaves for more than 3 hours (preserving the tea leaves under anaerobic conditions), the tea leaves preserved under anaerobic conditions were found. For example, after steam heating for 10 to 30 minutes, air-dry, or put into a dryer at 80 ° C. or more for 5 hours or more, and dry the dried tea leaves with water, a water-miscible organic liquid, and water and a water-miscible organic liquid. It has been found that extraction should be performed at a boiling point of a solvent such as a mixture of the above for 30 to 60 minutes. The extract is concentrated by a usual method, or, if necessary, purified by activated clay, chromatography, etc., and then concentrated under reduced pressure to obtain a solid (active ingredient). Things.
【0012】このようにして得られた抽出物(固形物)
は、γ−アミノ酪酸の含有量が多く、これを配合した本
発明の口腔用組成物は、歯茎の血行促進作用と併せ、当
該抽出物に含まれている末梢血管拡張作用を有するテオ
フィリン、末梢神経刺激作用を有するカフェイン、末梢
血管強化及び抗炎症作用を有するフラボノイドが相乗的
に作用し合って口腔内の歯周組織を賦活し、速効的な血
行促進、抗炎症作用を顕著に発現せしめ、更に、アスパ
ラギン酸、グルタミン酸、アラニン、セリン、グルタミ
ン、アルギニン等のアミノ酸の保湿作用が口腔内に対し
ても緩和な作用を有する。The extract (solid matter) thus obtained
Has a high content of γ-aminobutyric acid, and the oral composition of the present invention containing the γ-aminobutyric acid, combined with the action of promoting blood circulation of gums, has a peripheral vasodilatory action contained in the extract, Caffeine having a nerve stimulating action, flavonoids having a peripheral blood vessel strengthening and an anti-inflammatory action act synergistically to activate periodontal tissue in the oral cavity, and exhibit a rapid and effective blood circulation promoting and anti-inflammatory action. Furthermore, the moisturizing action of amino acids such as aspartic acid, glutamic acid, alanine, serine, glutamine, arginine and the like has a mild action in the oral cavity.
【0013】また、嫌気的条件下での茶葉の保存時間
が、室温では通常3時間以上、好ましくは5時間以上、
より好ましくは8時間以上である。保存時間が短いとγ
−アミノ酪酸等の生成は充分でなく、前記目的の口腔内
の血行促進、抗炎症作用の効果が充分に発現し難い。The storage time of tea leaves under anaerobic conditions is usually at least 3 hours at room temperature, preferably at least 5 hours.
More preferably, it is 8 hours or more. Short storage time γ
-Production of aminobutyric acid and the like is not sufficient, and it is difficult to sufficiently achieve the above-mentioned effects of promoting blood circulation in the oral cavity and anti-inflammatory effects.
【0014】尚、前記の溶剤における、水混和性有機液
体(親水性有機液体)としては、例えば、エチレングリ
コール、プロピレングリコール、1,3−ブチレングリ
コール、ジエチレングリコール等のグリコール類、グリ
セリン、マルチトール等の多価アルコール類、エチルア
ルコール、プロピルアルコール、ブチルアルコール等の
低級一価アルコール、アセトン、メチルエチルケトン等
の水混和性ケトン類、テトロヒドフラン等が挙げられ
る。The water-miscible organic liquid (hydrophilic organic liquid) in the above solvent includes, for example, glycols such as ethylene glycol, propylene glycol, 1,3-butylene glycol and diethylene glycol, glycerin, maltitol and the like. Polyhydric alcohols, lower monohydric alcohols such as ethyl alcohol, propyl alcohol and butyl alcohol, water-miscible ketones such as acetone and methyl ethyl ketone, and tetrohydrfuran.
【0015】本発明に用いる茶の生葉は、やぶきた種、
べにふじ種等いずれの品種でも適用が可能であり、また
摘採時期は特に限定されない。The fresh leaves of tea used in the present invention are:
Any varieties such as alley and fuji can be applied, and the time of plucking is not particularly limited.
【0016】また、本発明における前記の処理を行って
得られた茶葉の抽出物の配合量は、その固型分として当
該口腔用組成物の総量を基準として、0.01重量%
(以下wt%と略記する)以上であり、好ましくは1〜
10wt%である。すなわち、これが10wt%未満で
は本発明が目的としている口腔内の抗炎症効果が期待す
る程に発現せず、また10wt%を越えてもその増加分
に見合った効果は望めないので経済的に望ましくない。The amount of the tea leaf extract obtained by performing the above-mentioned treatment in the present invention is 0.01% by weight based on the total amount of the oral composition as a solid component.
(Hereinafter abbreviated as wt%), preferably 1 to
10 wt%. That is, if it is less than 10 wt%, the anti-inflammatory effect in the oral cavity intended by the present invention will not be exhibited as expected, and if it exceeds 10 wt%, the effect corresponding to the increase cannot be expected, so that it is economically desirable. Absent.
【0017】本発明に係る口腔用組成物は、練歯磨、粉
歯磨、水歯磨等の歯磨類、マウスウオッシュ、口中清涼
剤、トローチ、パスタ、塗付剤等に適用される。その
他、チューインガム、キャンディー、グミキャンデー、
アメ等も挙げられる。The composition for oral cavity according to the present invention is applied to dentifrices such as toothpaste, powdered toothpaste, water dentifrice, mouthwash, mouth freshener, troche, pasta, paint and the like. In addition, chewing gum, candy, gummy candy,
Also include candy and the like.
【0018】本発明の口腔用組成物中における上記抽出
物含有量は、有効濃度等の因子を考慮して決定すればよ
いが、その固形分として0.01%(重量%以下同じ)
〜10%、特に0.05〜5%とすることが好ましい。The content of the extract in the composition for oral cavity of the present invention may be determined in consideration of factors such as the effective concentration and the like.
It is preferably set to 10% to 10%, particularly preferably 0.05% to 5%.
【0019】本発明の他の配合成分は、口腔用組成物の
種類に応じて適宜選択される。例えば練歯磨の場合は、
一般に研磨剤として使用されている炭酸カルシウム、炭
酸マグネシウム、第2リン酸カルシウム、第3リン酸カ
ルシウム、リン酸マグネシウム、シリカ、ゼオライト、
メタリン酸ナトリウム、水酸化アルミニウム、水酸化マ
グネシウム、ピロリン酸カルシウム、ベンガラ、硫酸カ
ルシウム、無水ケイ酸等が挙げられる。The other components of the present invention are appropriately selected according to the type of the oral composition. For example, for toothpaste,
Calcium carbonate, magnesium carbonate, dibasic calcium phosphate, tribasic calcium phosphate, magnesium phosphate, silica, zeolite, which are generally used as abrasives,
Examples include sodium metaphosphate, aluminum hydroxide, magnesium hydroxide, calcium pyrophosphate, red iron oxide, calcium sulfate, and silicic anhydride.
【0020】また、カルボキシメチルセルロース、カル
ボキシメチルセルロースナトリウム、ヒドロキシエチル
セルロース、アルギン酸塩、カラギーナン、アラビアガ
ム、ポリビニルアルコール、メチルセルロース、酸化マ
グネシウム、アルミナゾル、ケイ酸カルシウム、ペクチ
ン、グアガム、カオリン等の粘結剤、ラウリル硫酸ナト
リウム、ドデシルベンゼンスルホン酸ナトリウム、ラウ
ロイルスルホ酢酸ナトリウム、N−ラウリルスルホン酸
ナトリウム、N−ラウロイルザルコシン酸ナトリウム、
ショ糖脂肪酸エステル、ポリオキシエチレンソルビタ
ン、アルキロールアミド等の発泡剤が使用される。Also, a binder such as carboxymethylcellulose, sodium carboxymethylcellulose, hydroxyethylcellulose, alginate, carrageenan, gum arabic, polyvinyl alcohol, methylcellulose, magnesium oxide, alumina sol, calcium silicate, pectin, guar gum, kaolin and the like, lauryl sulfate Sodium, sodium dodecylbenzene sulfonate, sodium lauroyl sulfoacetate, sodium N-lauryl sulfonate, sodium N-lauroyl sarcosinate,
A foaming agent such as sucrose fatty acid ester, polyoxyethylene sorbitan, or alkylolamide is used.
【0021】更に、サッカリンナトリウム、ステビオサ
イト、グリチルリチン、カルコン、ジヒドロカルコン等
の甘味料、グリセリン、ソルビトール、プロピレングリ
コール、ポリエチレングリコール、キリシトール、ジプ
ロピレングリコール、乳酸ナトリウム、マルチトール等
の保湿剤、パラオキシ安息香酸等の防腐剤、ペパーミン
ト、スペアミント精油、 −メントール等の香料、その
他乳酸アルミニウム、エデト酸塩、色素、BHT等が使
用され、必要に応じてその他の有効成分として塩化リゾ
チーム、デキストラーゼ、溶菌酵素、ムタナーゼ、ソル
ビン酸、アレキシジン、セチルピリジニウムクロライ
ド、アルキルグリシン、塩化ナトリウム、アラントイ
ン、ε−アミノカプロン酸、トラネキサム酸、アズレ
ン、フッ化ナトリウム、モノフルオロリン酸ナトリウム
等のフッ化物、イソプロピルメチルフェノール、ポリエ
チレングリコール、ポリビニルピロリドン、グリチルリ
チン、グリチルリチン酸、ヒノキチオール、ビタミンE
等も使用することができる。そして、これらの成分と水
とを混合し、常法に従い製造する。Further, sweeteners such as sodium saccharin, steviosite, glycyrrhizin, chalcone, dihydrochalcone, humectants such as glycerin, sorbitol, propylene glycol, polyethylene glycol, chylesitol, dipropylene glycol, sodium lactate, maltitol, paraoxybenzoate Preservatives such as acids, peppermint, spearmint essential oil, fragrances such as menthol, other aluminum lactate, edetates, pigments, BHT, etc. are used, and if necessary, lysozyme chloride, dextranase, lytic enzyme as other active ingredients. , Mutanase, sorbic acid, alexidine, cetylpyridinium chloride, alkylglycine, sodium chloride, allantoin, ε-aminocaproic acid, tranexamic acid, azulene, sodium fluoride, Fluorides such fluoro sodium phosphate, isopropyl methyl phenol, polyethylene glycol, polyvinyl pyrrolidone, glycyrrhizin, glycyrrhizic acid, hinokitiol, vitamin E
Etc. can also be used. Then, these components and water are mixed and manufactured according to a conventional method.
【0022】また、マウスウオッシュ、トローチ、チュ
ーイングガムその他においても製品の性状に応じた成分
が適宜配合される。In addition, components such as mouthwash, troche, chewing gum and the like depending on the properties of the product are appropriately blended.
【0023】[0023]
【実施例】以下、実施例及び比較例に基づき本発明を詳
細に説明する。 [嫌気的条件下で処理した茶葉抽出物の製造方法]摘採
した茶生葉500gを2l入り真空用デシケーターに入
れ、その上に磁器製の多孔質板を乗せ、縁にグリースを
塗布した蓋で密封してから、真空にし、更に窒素ボンベ
に接続をして容器内に窒素を流入せしめ、容器内の圧力
が0.8気圧になったところで窒素の流入を中止し、室
温25℃にて約10時間放置する。その後、嫌気的条件
下で処理した茶葉を容器より取出し、蒸篭に入れて30
分間蒸気で蒸してから乾燥したタオルの上に広げ、2昼
夜25℃の部屋に放置して自然乾燥する。The present invention will be described in detail below based on examples and comparative examples. [Production method of tea leaf extract treated under anaerobic conditions] 500 g of freshly picked tea leaves are placed in a vacuum desiccator containing 2 liters, a porcelain porous plate is placed thereon, and the edges are sealed with a lid coated with grease. After that, the vessel was evacuated and connected to a nitrogen cylinder to allow nitrogen to flow into the vessel. When the pressure in the vessel reached 0.8 atm, the flow of nitrogen was stopped. Leave for a time. Thereafter, the tea leaves treated under anaerobic conditions are taken out of the container and put in a steaming basket for 30 minutes.
After steaming for a minute, spread on a dried towel and leave it in a room at 25 ° C for 2 days and night to dry naturally.
【0024】このようにして得られた茶葉100gを5
00ml入のビーカーに入れ、25℃水又は10%エチ
ルアルコール水溶液を300ml注入し、30分間加熱
した後、ろ別し、滴下せる抽出物300mlを得た。次
に通常行われてている減圧下での濃縮法等で抽出物を濃
縮し、固形物4.6gを歯磨等に配合して各試験試料を
調製した。100 g of the tea leaf thus obtained is
In a beaker containing 00 ml, 300 ml of 25 ° C. water or a 10% aqueous solution of ethyl alcohol was injected, heated for 30 minutes, and filtered to obtain 300 ml of an extract to be dropped. Next, the extract was concentrated by a conventional concentration method under reduced pressure or the like, and 4.6 g of a solid substance was mixed with toothpaste or the like to prepare each test sample.
【0025】尚、本製造法によって得られた抽出物を分
析した結果を、茶葉紂の成分含有量(抽出物の含有量よ
り換算)と共に表1に示す。The results of analysis of the extract obtained by the present production method are shown in Table 1 together with the component contents of the tea leaves (converted from the extract content).
【0026】[0026]
【表1】 [Table 1]
【0027】また、本発明の口腔用組成物の血行促進、
抗炎症作用に対して、試作品を用いて連用テストを行い
歯肉の炎症性変化の改善を観察した。Further, the composition for oral cavity of the present invention promotes blood circulation,
For the anti-inflammatory effect, a continuous test was carried out using prototypes, and improvement in inflammatory changes in the gingiva was observed.
【0028】(1)上顎前歯上部及び下顎前歯下部に歯
周疾患のあるもの20名に対して表2に示す組成のもの
につき4週間の連用テストを行った。10名に対し1日
2回約1g実施例1(試料A)をハブラシに塗布し、残
り10名には比較例1(試料B)を同様に使用させた。
使用に際し、20名同じハブラシを使用し、ブラッシン
グの方法も説明し、なるべく同じ条件になるようにし
た。試験開始前後の歯肉の発赤、歯肉の腫脹、歯肉の出
血について観察した。(1) Twenty subjects with periodontal disease in the upper and lower front teeth of the upper and lower mandibular teeth were subjected to a continuous test for 4 weeks with the compositions shown in Table 2. About 1 g of Example 1 (Sample A) was applied to a toothbrush twice a day for 10 persons, and Comparative Example 1 (Sample B) was similarly used for the remaining 10 persons.
At the time of use, the same toothbrush was used by 20 people, the brushing method was also explained, and the same conditions were used as much as possible. Gingival redness, gingival swelling, and gingival bleeding before and after the test were observed.
【0029】[0029]
【表2】 [Table 2]
【0030】調製法は、通常の練歯磨の方法に準じた。The preparation method was in accordance with the usual toothpaste method.
【0031】本発明の組成物は、表3の如く、比較例の
ものと比べ諸特性の全てにわたり優れていることがわか
る。As can be seen from Table 3, the composition of the present invention is superior in all of the properties as compared with those of the comparative examples.
【0032】[0032]
【表3】 [Table 3]
【0033】実施例2;練歯磨 第2リン酸カルシウム・2水塩 45(wt%) 無水ケイ酸 10 グリセリン 15 酸化チタン 5 カルボキシメチルセルロースナトリウム 1 ラウリル硫酸ナトリウム 0.5 香料 0.7 サッカリンナトリウム 0.1 茶葉抽出物 0.1 水 残りExample 2 Toothpaste Dibasic calcium phosphate dihydrate 45 (wt%) Silicic anhydride 10 Glycerin 15 Titanium oxide 5 Sodium carboxymethylcellulose 1 Sodium lauryl sulfate 0.5 Fragrance 0.7 Sodium saccharin 0.1 Tea leaf extraction Thing 0.1 water remaining
【0034】実施例3;洗口液 エタノール 8(wt%) グリセリン 5 ポリオキシエチレン硬化ヒマシ油 0.7 安息香酸ナトリウム 0.1 香料 0.5 茶葉抽出物 0.2 ラウリル硫酸ナトリウム 0.3 水 残りExample 3 Mouthwash Ethanol 8 (wt%) Glycerin 5 Polyoxyethylene hydrogenated castor oil 0.7 Sodium benzoate 0.1 Fragrance 0.5 Tea leaf extract 0.2 Sodium lauryl sulfate 0.3 Water remaining
【0035】実施例4;口中清涼剤 エタノール 15(wt%) グリセリン 3 ポリオキシエチレン硬化ヒマシ油 0.5 サッカリンナトリウム 0.1 香料 0.2 茶葉抽出物 2.0 水 残りExample 4: Mouth freshener ethanol 15 (wt%) glycerin 3 polyoxyethylene hydrogenated castor oil 0.5 saccharin sodium 0.1 flavor 0.2 tea leaf extract 2.0 water remaining
【0036】実施例5;粉歯磨 第2リン酸カルシウム 45(wt%) 炭酸カルシウム 35 グリセリン 5 デキストリン 1 メチルセルロース 1 サッカリンナトリウム 0.05 香料 0.2 ラウリル硫酸ナトリウム 0.5 茶葉抽出物 1.5 水 残りExample 5: Toothpaste Dibasic calcium phosphate 45 (wt%) Calcium carbonate 35 Glycerin 5 Dextrin 1 Methylcellulose 1 Saccharin sodium 0.05 Fragrance 0.2 Sodium lauryl sulfate 0.5 Tea leaf extract 1.5 Water Remaining
【0037】実施例6;チューイングガム ガムベース 45 (wt%) 粉糖 25 マンニット 20 ソルビトール 5 香料 0.5 茶葉抽出物 3 水 残りExample 6 Chewing gum Gum base 45 (wt%) Powdered sugar 25 Mannit 20 Sorbitol 5 Flavor 0.5 Tea leaf extract 3 Water Remaining
【0038】上記実施例2〜6の該抽出物を配合してな
る口腔用組成物を、各々10名の被験者が1ケ月間利用
した結果、歯肉の発赤、歯肉の腫脹、歯肉の出血等に対
する改善効果がみられた。また、使用中に苦み等の不快
感も感じなかった。[0038] As a result of the use of the oral composition prepared by blending the extracts of Examples 2 to 6 with 10 subjects each for one month, the composition was effective against gingival redness, gingival swelling, gingival bleeding and the like. An improvement effect was observed. No discomfort such as bitterness was felt during use.
【0039】[0039]
【発明の効果】以上より、本発明の口腔用組成物が、歯
肉の発赤、腫脹、出血等に対し改善効果を示し、更には
歯槽膿漏、歯肉炎等の予防にも優れた有用なる口腔用組
成物であることは明らかである。As described above, the oral composition of the present invention has an effect of improving gingival redness, swelling, bleeding, etc., and is also useful in preventing alveolar pyorrhea, gingivitis and the like. It is clear that this is a composition for use.
Claims (1)
蒸気加熱処理及び/又は乾燥処理し、これを抽出して得
られた茶葉抽出物を、その固形分として0.01重量%
以上配合したことを特徴とする口腔用組成物。Claims 1. After storing fresh tea leaves under anaerobic conditions,
Steam heating and / or drying and extracting
The extracted tea leaf extract as a solid content of 0.01% by weight
An oral composition characterized by being blended as described above.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3059754A JP2619841B2 (en) | 1991-02-28 | 1991-02-28 | Oral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3059754A JP2619841B2 (en) | 1991-02-28 | 1991-02-28 | Oral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04273814A JPH04273814A (en) | 1992-09-30 |
| JP2619841B2 true JP2619841B2 (en) | 1997-06-11 |
Family
ID=13122361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3059754A Expired - Lifetime JP2619841B2 (en) | 1991-02-28 | 1991-02-28 | Oral composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2619841B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3763075B2 (en) * | 1998-04-24 | 2006-04-05 | サンスター株式会社 | Food composition, oral composition and pharmaceutical composition for prevention or treatment of periodontal disease |
| US9236545B2 (en) | 2013-11-18 | 2016-01-12 | Ge Lighting Solutions Llc | Hybrid metallization on plastic for a light emitting diode (LED) lighting system |
| CN116725995B (en) * | 2023-06-20 | 2025-11-25 | 华熙生物科技股份有限公司 | The use of γ-aminobutyric acid (GABA) in preventing and/or improving gingival damage caused by cigarette smoke and methods for achieving this use. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2519182B2 (en) * | 1987-05-12 | 1996-07-31 | 鐘紡株式会社 | Hair nourishing cosmetics |
| JP2667422B2 (en) * | 1988-01-26 | 1997-10-27 | 株式会社伊藤園 | Gargle |
| JP2979514B2 (en) * | 1988-07-14 | 1999-11-15 | 株式会社伊藤園 | Method for producing caries preventive agent |
| JPH0253717A (en) * | 1988-08-18 | 1990-02-22 | Momotani Jiyuntenkan:Kk | Dentifrice or mouth wash |
-
1991
- 1991-02-28 JP JP3059754A patent/JP2619841B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04273814A (en) | 1992-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101955468B1 (en) | Preparing method for toothpaste composition comprising natural extracts | |
| JP2002529489A (en) | Flavor blends to mask the unpleasant taste of zinc compounds | |
| US8435499B2 (en) | Toothpowder composition containing wheat flour and bamboo salt | |
| EP3378466A1 (en) | Composition for use in oral cavity | |
| KR100447428B1 (en) | Oral solution composition | |
| US20070098650A1 (en) | Dental formulation | |
| KR100450391B1 (en) | Toothpaste Composition | |
| JP2619841B2 (en) | Oral composition | |
| JPH1171253A (en) | Salivary secretion promoter and oral composition | |
| JP2001151690A (en) | Composition for oral cavity | |
| JP3685470B2 (en) | Composition for promoting oral hygiene | |
| KR20160063814A (en) | Oral composition comprising fermented extract of blackberry and manufacturing method thereof | |
| KR101660467B1 (en) | Oral composition containing fermentative extract of lycii fructus as active ingredient | |
| JP2016504279A (en) | Oral care composition containing theaflavin extract | |
| JP3690442B2 (en) | Salivary secretion promoter, oral composition and denture stabilizer | |
| KR100941670B1 (en) | Oral hygiene composition containing vegetable abrasive | |
| JPH0624951A (en) | Composition for oral cavity | |
| KR20220006337A (en) | Composition for teeth whitening containing hydroxy apatite and lettuce extract | |
| JPH06219930A (en) | Composition for oral cavity | |
| KR20090091898A (en) | Oral compositions containing luffa cylindrica | |
| KR0149483B1 (en) | Antiplague compositions | |
| JP2763824B2 (en) | Oral composition | |
| KR101344803B1 (en) | Oral care composition comprising extract of machilus thunbergii and sequestering agent | |
| KR102798454B1 (en) | Hydro hydrogen toothpaste | |
| RP et al. | FORMULATION AND EVALUATION OF RICE BRAN OIL INCORPORATED TOOTHPASTE FOR ORAL HYGIENE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S202 | Request for registration of non-exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R315201 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080311 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090311 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090311 Year of fee payment: 12 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090311 Year of fee payment: 12 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090311 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100311 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110311 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110311 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110311 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110311 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110311 Year of fee payment: 14 |
|
| EXPY | Cancellation because of completion of term |